Arterial Thromboembolism

Arterial thromboembolism represents a significant complication for patients with cancer, particularly those with hematologic malignancies. Fillmore and his collaborators established that the cumulative incidence of these events increases over time, reaching 2.8% at five years following diagnosis. His research demonstrates that the risk of heart attack and stroke in this population is independently driven by the specific malignancy type and traditional cardiovascular risk factors.